GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
PMARX
Price
$13.46
Change
+$0.06 (+0.45%)
Updated
Aug 21 closing price
Net Assets
172.17M
Interact to see
Advertisement

GSPQX vs PMARX

GSPQX vs PMARX Comparison Chart in %
View a ticker or compare two or three
VS
GSPQX vs. PMARX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPQX is a StrongBuy and PMARX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. PMARX (172M). PMARX pays higher dividends than GSPQX: PMARX (10.35) vs GSPQX (0.06). GSPQX was incepted earlier than PMARX: GSPQX (21 years) vs PMARX (16 years). GSPQX (1.86) is less costly to investors than PMARX (1.32). PMARX is a more actively managed with annual turnover of: 65.00 vs. GSPQX (29.00). GSPQX has a lower initial minimum investment than PMARX: GSPQX (1000) vs PMARX (2500). PMARX annual gain was more profitable for investors over the last year : 15.70 vs. GSPQX (13.89). PMARX (28.52) and GSPQX (27.70) have equivalent 5 years return.
GSPQXPMARXGSPQX / PMARX
Total Expense Ratio1.751.20146%
Annual Report Gross Expense Ratio1.861.32141%
Fund Existence21 years16 years-
Gain YTD12.65111.030115%
Front LoadN/A5%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B172M2,290%
Annual Yield % from dividends0.0610.351%
Returns for 1 year13.8915.7088%
Returns for 3 years39.7750.3479%
Returns for 5 years27.7028.5297%
Returns for 10 years75.0257.06131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals